These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9853390)

  • 1. Eyes closed: simple, intuitive, statistically sound, and efficient methods for estimating parameters of clonal growth cancer models.
    Sherman CD; Portier CJ
    Risk Anal; 1998 Oct; 18(5):529-34. PubMed ID: 9853390
    [No Abstract]   [Full Text] [Related]  

  • 2. Computer simulation of clonal growth cancer models. I. Parameter estimation using an iterative absolute bisection algorithm.
    Kramer DA; Conolly RB
    Risk Anal; 1997 Feb; 17(1):115-26. PubMed ID: 9131830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoproliferation and cancer: a common macrophage-derived promoter substance.
    Salmon SE; Hamburger AW
    Lancet; 1978 Jun; 1(8077):1289-90. PubMed ID: 78051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nonidentifiability aspect of the two-stage model of carcinogenesis.
    Hanin LG; Yakovlev AYu
    Risk Anal; 1996 Oct; 16(5):711-5. PubMed ID: 8962520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consilience across evolving dysplasias affecting myeloid, cervical, esophageal, gastric and liver cells: common themes and emerging patterns.
    Raza A
    Leuk Res; 2000 Jan; 24(1):63-72. PubMed ID: 10634648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer simulation of cell growth governed by stochastic processes: application to clonal growth cancer models.
    Conolly RB; Kimbell JS
    Toxicol Appl Pharmacol; 1994 Feb; 124(2):284-95. PubMed ID: 8122275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using cell replication data in mathematical modeling in carcinogenesis.
    Portier CJ; Kopp-Schneider A; Sherman CD
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):79-86. PubMed ID: 8013428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic instability and clonal expansion.
    Nowak MA; Michor F; Iwasa Y
    J Theor Biol; 2006 Jul; 241(1):26-32. PubMed ID: 16405914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heritable tumor cell division rate heterogeneity induces clonal dominance.
    Palm MM; Elemans M; Beltman JB
    PLoS Comput Biol; 2018 Feb; 14(2):e1005954. PubMed ID: 29432417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A validation of the parametric assessment of the time of clonogen progression by simulation modelling].
    Ivankov AA; Tsodikov AD; Iakovlev AIu
    Vopr Onkol; 1993; 39(4-6):220-5. PubMed ID: 7975401
    [No Abstract]   [Full Text] [Related]  

  • 11. A progression puzzle.
    Bernards R; Weinberg RA
    Nature; 2002 Aug; 418(6900):823. PubMed ID: 12192390
    [No Abstract]   [Full Text] [Related]  

  • 12. Transient appearance of the mutator phenotype during carcinogenesis as a possible explanation for the lack of mini/microsatellite instability in many late stage tumors.
    Stark AA
    Mutat Res; 1998 Nov; 421(2):221-5. PubMed ID: 9852996
    [No Abstract]   [Full Text] [Related]  

  • 13. Limits of applicability for the deterministic approximation of the two-step clonal expansion model.
    Heidenreich WF; Hoogenveen R
    Risk Anal; 2001 Feb; 21(1):103-5. PubMed ID: 11332539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of cancer incidence data on the basis of multistage and clonal growth models.
    Stein WD
    Adv Cancer Res; 1991; 56():161-213. PubMed ID: 2028841
    [No Abstract]   [Full Text] [Related]  

  • 15. Incorporating additional biological phenomena into two-stage cancer models.
    Sielken RL; Bretzlaff RS; Stevenson DE
    Prog Clin Biol Res; 1994; 387():237-60. PubMed ID: 7972250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Order-of-magnitude estimates of latency (time to appearance) and refill time of a cancer from a single cancer 'stem' cell compared by an exponential and a logistic equation.
    Anderson KM; Rubenstein M; Guinan P; Patel M
    In Vivo; 2012; 26(2):183-9. PubMed ID: 22351656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A stochastic two-stage model for cancer risk assessment. II. The number and size of premalignant clones.
    Dewanji A; Venzon DJ; Moolgavkar SH
    Risk Anal; 1989 Jun; 9(2):179-87. PubMed ID: 2762604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the MVK stochastic carcinogenesis model with Erlang distributed cell life lengths.
    Zheng Q
    Risk Anal; 1995 Aug; 15(4):495-502. PubMed ID: 7480949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuropeptides and neoplasms].
    Pawlikowski M
    Pol Arch Med Wewn; 1988 Apr; 79(4):177-80. PubMed ID: 2908386
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor initiation and promotion.
    Scribner JD; Süss R
    Int Rev Exp Pathol; 1978; 18():137-98. PubMed ID: 149093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.